Inositol hexaphosphate (IP6) as an anti-neoplastic and lipid-lowering agent

Anticancer Research

Volumn 19, Issue 5 A, 1999, Pages 3699-3702

  Jariwalla, Raxit J ^a  

^a CALIFORNIA INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

Cholesterol; Hyperlipidemia; Phytate; Triglycerides; Zinc copper ratio

Indexed keywords

ANTILIPEMIC AGENT; ANTINEOPLASTIC AGENT; CHOLESTEROL; COPPER; LIPID; MAGNESIUM OXIDE; MINERAL; PHYTIC ACID; SATURATED FATTY ACID; TRIACYLGLYCEROL; ZINC;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; CANCER INCIDENCE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FIBROSARCOMA; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; MINERAL BLOOD LEVEL; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL; TUMOR; TUMOR GROWTH;

EID: 0032785868     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Jariwalla RJ, Sabin R, Lawson S et al: Effects of dietary phytic acid (phytate) on the incidence and growth rate of tumors promoted in Fischer rats by a magnesium supplement. Nutrition Res 8: 813-827, 1988.
2. Jariwalla RJ, Sabin R, Lawson S, Herman Z: Lowering of serum cholesterol and triglycerides and modulation of divalent cations by dietary phytate. J Applied Nutrition 42: 18-28, 1990.
3. Graf E: Applications of phytic acid. J Am Oil Chem Soc 60: 1861-1867, 1983.
4. Berridge MJ: Inositol triphosphate and calcium signalling. Nature 361: 315-325, 1993.
5. Anderson RJ: A contribution to the chemistry of phytin. J Biol Chem 17: 171-190, 1914.
6. Johnson LF, Tate ME: Structure of "phytic acids". Can J Chem 47: 63-73, 1969.
7. Rubin H: Central role for magnesium in coordinate control of metabolism and growth in animal cells. Proc Natl Acad Sci USA 72: 3551-3555, 1975.
8. Mills BJ, Broghamer WL, Higgins PJ, Lindeman RD: Inhibition of tumor growth by zinc depletion of rats. J Nutr 114: 746-752, 1984.
9. Klevay LM: Coronary heart disease: the zinc/copper hypothesis. Perspectives in nutrition. Am J Clin Nutr 28: 764-774, 1975.
10. Mathur KS, Singhal SS, Sharma RD: Effect of Bengal gram on experimentally induced high levels of cholesterol in tissue and serum in albino rats. J Nutr 84: 201-204, 1964.
11. Shamsuddin AM, Elsayed AM, Ullah A Suppression of large intestinal cancer in F344 rats by inositol hexaphosphate. Carcinogenesis 9: 577-580, 1988.
12. Vucenik I et al: Inhibition of rat mammary tumorigenesis by inositol hexaphosphate (phytic acid). A pilot study. Cancer Letters 75: 96-102, 1993.
13. Hirose M, Ozaki K, Takaba K et al: Modifying effects of the naturally occurring antioxidants gamma- oxyzanol, phytic acid, tannic acid and n-tritriacontane-16, 18-dione in a rat wide-spectrum organ carcinogenesis model. Carcinogenesis 88: 1917-21, 1991.
14. Vucenik I, Zhang ZS, Shamsuddin AM: IP6 in treatment of liver cancer II. Intra-tumoral injection of IP6 regresses pre-existing human liver cancer xenotransplanted in nude mice. Anticancer Res 18: 4091-4096, 1998.
15. Vucenik I, Kalebic T, Tantivejkul K, Shamsuddin AM: Novel anticancer function of inositol hexaphosphate: inhibition of human rhabdomyosarcoma in vitro and in vivo. Anticancer Res 18: 1377-1384, 1998.
16. Pretlow TP, O'Riordan MA, Somich G et al: Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis 13: 1509-1512, 1992.
17. Thompson L, Zhang L: Phytic acid and minerals: effect on early markers of risk for mammary and colon carcinogenesis. Carcinogenesis 12: 2041-2045, 1991.
18. Van Den Berg CJ, Hill LF, Stanbury SW: Inositol phosphates and phytic acid as inhibitors of biological calcification in the rat. Clin Sci 43: 377-383, 1972.
19. Green CJ, Simpkins S, Healing G, Grover JD: D-myo-inositol-1,2,6-triphosphate (PP56) inhibits lipid peroxidation in warm ischemic rabbit kidneys. Med Sci Res 17: 749-750, 1989.
20. Saied IT, Shamsuddin AM: Up-regulation of the tumor suppressor gene p53 and WAF1 gene expression by IP6 in HT-29 human colon carcinoma cell line. Anticancer Res 18: 1479-1484, 1998.